Fortunately, over the years we have identified some key events that exacerbate certain disorders, such as the downregulation of potassium channel Kir4.1, or glutamate transporter, Glt1, in Huntington’s disease and amyloid lateral sclerosis[8, 17]. This evidence concerns the gene SLC1A2 and Huntington disease.